Functional gastrointestinal diseases, accounting for more than 50% of gastroenterology outpatients. Such as abdominal bloating or flatulence, loss of appetite, early satiety, heartburn, hiccups, belching, anorexia, nausea, vomiting, acid reflux or food regurgitation, gastroparesis, indescribable epigastric discomfort, diarrhea, constipation and defecation difficulties and so on. In view of the above phenomenon, often need to rely on drugs to improve gastrointestinal function. However, drug therapy has great limitations, easy to produce drug resistance and side effects, and the treatment effect is not ideal. Patients with recurrent symptoms and persistent treatment not only seriously affect the quality of life and physical and mental health, but also cause a large amount of medical resources consumption. The Affiliated Hospital of Inner Mongolia Medical University is the first to introduce biofeedback gastrointestinal motility instrument, which can detect and treat the above problems. The functions and advantages of this instrument are described in detail below.

The integration of detection and treatment opens a new experience of gastrointestinal diagnosis and treatment

　　What is functional gastrointestinal disease?

　　functional gastrointestinal diseases (FGIDs) is a common and frequent disease of digestive system. In recent years, with the rapid pace of society, the change of living habits and the increasing senility, the prevalence of FGIDs is increasing.

　　The main characteristics of FGIDs are: ① Gastrointestinal diseases characterized by loss of appetite, dyspepsia, frequent nausea and vomiting, abdominal pain, diarrhea, or constipation. There is no clear organic disease, such as gastritis, enteritis. ③ The course of disease is long and easy to repeat. ④ The incidence of the general population is as high as 70%.

　　Classification of Roman Ⅲ FGIDs

　　Current status of diagnosis and treatment of functional gastrointestinal diseases

　　1. Current status of diagnosis and treatment of functional gastrointestinal diseases: without organic pathological changes, it is difficult to obtain objective diagnostic basis through relevant technical equipment. At present, empirical treatment is mainly based on clinical symptoms.

　　2. Unsatisfactory treatment effect: The pathogenesis is complex and unclear. Traditional treatment mainly relies on drugs, which is prone to drug resistance and side effects, resulting in unsatisfactory treatment effect.

　　3. The disease has great harm: the patient's symptoms are repeated and refractory to long-term treatment, which not only seriously affects the quality of life and physical and mental health, but also can induce other diseases.

Principles of gastrointestinal pacing and treatment

　　Gastrointestinal pacemaker

　　The movement of the gastrointestinal tract is caused by the regular contraction and relaxation of smooth muscle. A specific area of the gastrointestinal tract can drive the contraction of gastrointestinal smooth muscle and control the basic bioelectrical rhythm of the gastrointestinal tract. Medically, this specific area is called the gastrointestinal pacemaker.

　　Treatment principle

　　① A specific region of the gastrointestinal tract can drive gastrointestinal smooth muscle contraction and control the basic bioelectrical rhythm of the gastrointestinal tract. ② Biofeedback gastrointestinal motility instrument simulates the normal gastrointestinal bioelectrical signal, acts on the gastrointestinal pacemaker, makes the electrical activity of the gastrointestinal pacemaker produce 'following effect', corrects the abnormal gastrointestinal peristaltic rhythm and promotes the movement trend to normalize, and achieves the purpose of treating functional gastrointestinal diseases.

Scope of clinical application

　　1. Patients with postoperative mobility difficulties or long-term bed rest will have gastrointestinal function decline and disorder, gastroparesis, constipation, postprandial discomfort syndrome and other phenomena. Biofeedback gastrointestinal motility instrument can promote gastrointestinal peristalsis, accelerate the recovery of postoperative intestinal function, accelerate exhaust, regulate gastrointestinal function and normalize it.

　　2. For patients in geriatrics/rehabilitation department with decreased digestive function, slow gastrointestinal motility, functional disorder, constipation, dyspepsia and other symptoms, biofeedback gastrointestinal motility instrument can be used as a drug-assisted means to help patients improve gastrointestinal function and accelerate gastrointestinal motility.

　　3. Endocrine diabetic gastroparesis patients have gastric peristalsis rhythm disorder, delayed gastric empties, constipation, diarrhea and other phenomena. Biofeedback gastrointestinal motility instrument can help diabetic gastroparesis patients promote gastrointestinal peristalsis, enhance nutritional absorption, reduce medication, and improve their own immunity.

　　4. For patients in the Department of obstetrics and Gynecology/women's health care, who have persistent difficulty in defecation, reduced frequency of defecation or feeling of incomplete defecation, biofeedback gastrointestinal motility instrument can help women with gastrointestinal conditioning and treatment of constipation.

　　5. Children usually have stomach distension, stomach pain, diarrhea, constipation and other phenomena after dyspepsia, which affect children's absorption of nutrients. If not treated early, it can also affect a child's development and intelligence. For pediatric/childcare children, constipation, diarrhea, dyspepsia and other phenomena, often need to rely on drugs to improve gastrointestinal function, accelerate gastrointestinal peristalsis. However, drug therapy has great limitations, easy to produce drug resistance and side effects. In addition, children's compliance is poor, and the treatment effect is not ideal. As a new way of surface diagnosis and treatment, biofeedback gastrointestinal motility instrument can help children to relieve their troubles.